全文获取类型
收费全文 | 4077篇 |
免费 | 288篇 |
国内免费 | 72篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 149篇 |
妇产科学 | 96篇 |
基础医学 | 468篇 |
口腔科学 | 77篇 |
临床医学 | 417篇 |
内科学 | 1006篇 |
皮肤病学 | 66篇 |
神经病学 | 233篇 |
特种医学 | 319篇 |
外科学 | 608篇 |
综合类 | 80篇 |
预防医学 | 285篇 |
眼科学 | 73篇 |
药学 | 259篇 |
中国医学 | 22篇 |
肿瘤学 | 238篇 |
出版年
2023年 | 30篇 |
2022年 | 77篇 |
2021年 | 116篇 |
2020年 | 77篇 |
2019年 | 117篇 |
2018年 | 136篇 |
2017年 | 70篇 |
2016年 | 75篇 |
2015年 | 111篇 |
2014年 | 145篇 |
2013年 | 188篇 |
2012年 | 242篇 |
2011年 | 244篇 |
2010年 | 167篇 |
2009年 | 135篇 |
2008年 | 188篇 |
2007年 | 212篇 |
2006年 | 160篇 |
2005年 | 160篇 |
2004年 | 162篇 |
2003年 | 129篇 |
2002年 | 116篇 |
2001年 | 47篇 |
2000年 | 56篇 |
1999年 | 64篇 |
1998年 | 76篇 |
1997年 | 54篇 |
1996年 | 85篇 |
1995年 | 63篇 |
1994年 | 60篇 |
1993年 | 69篇 |
1992年 | 46篇 |
1991年 | 45篇 |
1990年 | 51篇 |
1989年 | 75篇 |
1988年 | 77篇 |
1987年 | 68篇 |
1986年 | 57篇 |
1985年 | 58篇 |
1984年 | 39篇 |
1983年 | 30篇 |
1982年 | 20篇 |
1981年 | 29篇 |
1980年 | 34篇 |
1979年 | 31篇 |
1978年 | 31篇 |
1977年 | 27篇 |
1976年 | 14篇 |
1975年 | 14篇 |
1973年 | 11篇 |
排序方式: 共有4437条查询结果,搜索用时 31 毫秒
61.
FJ Cowan JT Warner LM Lowes JP Riberio JW Gregory 《Archives of disease in childhood》1997,77(2):109-114
AIMS: To define outcome measures for auditing the clinical care of children and adolescents with insulin dependent diabetes mellitus (IDDM) and to assess the benefit of appointing a dedicated paediatric trained diabetes specialist nurse (PDSN). METHODS: Retrospective analysis of medical notes and hospital records. Glycaemic control, growth, weight gain, microvascular complications, school absence, and the proportion of children undergoing an annual clinical review and diabetes education session were assessed. The effect of the appointment of a PDSN on the frequency of hospital admission, length of inpatient stay, and outpatient attendance was evaluated. RESULTS: Children with IDDM were of normal height and grew well for three years after diagnosis, but grew suboptimally thereafter. Weight gain was above average every year after diagnosis. Glycaemic control was poor at all ages with only 16% of children having an acceptable glycated haemoglobin. Eighty five per cent of patients underwent a formal annual clinical review, of whom 16% had background retinopathy and 20% microalbuminuria in one or more samples. After appointing the PDSN the median length of hospital stay for newly diagnosed patients decreased from five days to one day, with 10 of 24 children not admitted. None of the latter was admitted during the next year. There was no evidence of the PDSN affecting the frequency of readmission or length of stay of children with established IDDM. Non-attendance at the outpatient clinic was reduced from a median of 19 to 10%. CONCLUSIONS: Outcome measures for evaluating the care of children with IDDM can be defined and evaluated. Specialist nursing support markedly reduces the length of hospital stay of newly diagnosed patients without sacrificing the quality of care. 相似文献
62.
FJ Cowan JT Warner FD Dunstan WD Evans JW Gregory HR Jenkins 《Archives of disease in childhood》1997,76(4):325-329
The prevalence of osteopenia in children with inflammatory bowel disease (IBD) is unknown. The effect of nutritional state, disease activity, and steroid therapy on bone mineral content (BMC) of whole body, lumbar spine, and left femoral neck measured by dual energy x ray absorptiometry in 32 children with IBD was assessed by comparison with 58 healthy local school children. Using the control data, a predicted BMC was calculated taking into account bone area, age, height, weight, and pubertal stage. The measured BMC in children with IBD was expressed as a percentage of this predicted value (% BMC). Mean (SD) % BMC was significantly reduced for the whole body and left femoral neck in the children with IBD (97.0 (4.5)% and 93.1 (12.0)% respectively, p < 0.05). Of the children with IBD, 41% had a % BMC less than 1 SD below the mean for the whole body and 47% at the femoral neck. Reduction in % BMC was associated with steroid usage but not with the magnitude of steroid dose, disease activity, or biochemical markers of bone metabolism. In conclusion, osteopenia is relatively common in childhood IBD and may be partly related to the previous use of steroids. 相似文献
63.
BA Evans IA Hughes CL Bevan MN Patterson JW Gregory 《Archives of disease in childhood》1997,76(6):529-531
The androgen insensitivity syndrome is a heterogeneous disorder with a wide spectrum of phenotypic abnormalities, ranging from complete female to ambiguous forms that more closely resemble males. The primary abnormality is a defective androgen receptor protein due to a mutation of the androgen receptor gene. This prevents normal androgen action and thus leads to impaired virilisation. A point mutation of the androgen receptor gene affecting two siblings with partial androgen insensitivity syndrome is described. One had cliteromegaly and labial fusion and was raised as a girl, whereas the other sibling had micropenis and penoscrotal hypospadias and was raised as a boy. Both were shown to have the arginine 840 to cysteine mutation. The phenotypic variation in this family is thus dependent on factors other than abnormalities of the androgen receptor gene alone. 相似文献
64.
Immunobiology of T helper cells and antigen-presenting cells in autoimmune thrombocytopenic purpura (ITP) 总被引:1,自引:0,他引:1
JW Semple 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(S424):41-45
Autoimmune thrombocytopenic purpura (AITP) is a bleeding disease in which autoantibodies are directed against the individual's own platelets, resulting in enhanced Fc-mediated platelet destruction by macrophages in the reticuloendothelial system. Most research in AITP has focused on characterization of the autoantibodies, while little has been devoted to the cellular immune mechanisms leading to autoantibody production. This report summarizes the current state of the literature and argues that enhanced T helper cell/antigen-presenting cell interactions in patients with AITP are the primary stimulus for the development of antiplatelet autoantibody production. Understanding these events is important for eventually identifying disease-initiating platelet autoantigens and ultimately developing specific immunotherapies for AITP. 相似文献
65.
66.
C Ben Meriem S Nouri C Chouchane S Chouchane M Said L Ghédira A Moussa M Boubtane M N Guediche 《Archives de pédiatrie》2006,13(1):44-47
Langerhans cell histiocytose is a rare condition in childhood. It presents in different ways ranging from a single bony disease to a multisystemic disease involving vital organs. CASE REPORT: We report a case of single bone involvement revealed by torticollis in an eight-year-old boy. The diagnosis was evocated on radiological findings and confirmed by histologic aspects. After a period of 2,5 years, this child is in total spontaneous remission. CONCLUSION: Torticollis must be explored and watched. Eosinophilic granuloma can be a rare aetiology in children. The outcome is often favorable. 相似文献
67.
Timothy F Cloughesy John Kuhn H Ian Robins Lauren Abrey Patrick Wen Karen Fink Frank S Lieberman Minesh Mehta Susan Chang Alfred Yung Lisa DeAngelis David Schiff Larry Junck Morris Groves Steve Paquette John Wright Kathleen Lamborn Said M Sebti Michael Prados 《Journal of clinical oncology》2005,23(27):6647-6656
PURPOSE: To determine the maximum-tolerated dose (MTD), toxicities, and clinical effect of tipifarnib, a farnesyltransferase (FTase) inhibitor, in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs (EIAEDs). This study compares the pharmacokinetics and pharmacodynamics of tipifarnib at MTD in patients on and off EIAEDs. PATIENTS AND METHODS: Recurrent malignant glioma patients were treated with tipifarnib using an interpatient dose-escalation scheme. Pharmacokinetics and pharmacodynamics were assessed. RESULTS: Twenty-three assessable patients taking EIAEDs received tipifarnib in escalating doses from 300 to 700 mg bid for 21 of 28 days. The dose-limiting toxicity was rash, and the MTD was 600 mg bid. There were significant differences in pharmacokinetic parameters at 300 mg bid between patients on and not on EIAEDs. When patients on EIAEDs and not on EIAEDs were treated at MTD (600 and 300 mg bid, respectively), the area under the plasma concentration-time curve (AUC)(0-12 hours) was approximately two-fold lower in patients on EIAEDs. Farnesyltransferase inhibition was noted at all tipifarnib dose levels, as measured in peripheral-blood mononuclear cells (PBMC). CONCLUSION: Toxicities and pharmacokinetics differ significantly when comparing patients on or off EIAEDs. EIAEDs significantly decreased the maximum concentration, AUC(0-12 hours), and predose trough concentrations of tipifarnib. Even in the presence of EIAEDs, the levels of tipifarnib were still sufficient to potently inhibit FTase activity in patient PBMCs. The relevance of these important findings to clinical activity will be determined in ongoing studies with larger numbers of patients. 相似文献
68.
69.
Ignacio Mejía‐Calvo Leonardo E. Lpez‐Jurez Said Vzquez‐Leyva Carlos A. Lpez‐Morales Daniel Montoya‐Escutia Pamela G. Merlos Rivera Jos Enrique Herbert‐Pucheta Luis Gerardo Zepeda‐Vallejo Marco Velasco‐Velzquez Lenin Pavn Sonia M. Prez‐Tapia Emilio Medina‐Rivero 《Journal of Cosmetic Dermatology》2021,20(1):150-158
70.